You are using an older browser version. Please use a supported version for the best MSN experience.

FDA panel debates booster for single-dose vaccine

U.S. health advisers are meeting to tackle who needs boosters of Johnson & Johnson's single-shot COVID-19 vaccine and when. J&J wants its vaccine recipients to be eligible for another shot, citing increased protection after a second dose. (Oct. 15)
image beaconimage beaconimage beacon